Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jalil Rashedi

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Basic and Clinical Physiology and Pharmacology|August 11, 2021
Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibilityAmin Daei Sorkhabi, Aila Sarkesh, Alireza Daei Sorkhabi, et al.
Tanaffos|February 10, 2016
An Innovative Method to Enhance the Modified DOTS for TB PatientsHassan Yekrang Sis, Jalil Rashedi, Fariba Azabdaftari, et al.
Infectious Disorders Drug Targets|December 29, 2018
Stopping of the Downtrend of Tuberculosis in Iran, a Systematic Review of Associated Risk FactorsManouchehr Fadaee, Jalil Rashedi, Sepideh Arabi, et al.
Le Infezioni in Medicina|December 1, 2020
Risk Factors for COVID-19Jalil Rashedi, Behroz Mahdavi Poor, Vahid Asgharzadeh, et al.
Iranian Journal of Public Health|September 27, 2021
Why the COVID-19 Is Not Significantly Reduced in Iran?Mohammad Asgharzadeh, Behroz Mahdavipoor, Vahid Asgharzadeh, et al.
Iranian Journal of Allergy, Asthma, and Immunology|July 18, 2016
Association of Promoter Polymorphisms of Interleukin-10 and Interferon-Gamma Genes with Tuberculosis in Azeri Population of IranMohammad Asgharzadeh, Sajjad Ghorghanlu, Jalil Rashedi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 7, 2023
The Association between Diet and Multiple SclerosisVahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Behroz Mahdavi Poor, et al.
Infectious Disorders Drug Targets|July 20, 2019
Tuberculosis and Diabetes Mellitus in Northwest of IranMahdi Asghari Ozma, Jalil Rashedi, Behroz Mahdavi Poor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 28, 2026
Association Between Early-Life Self-Medication and Multiple Sclerosis Risk: A Case-Control StudySeyyed Amin Seyyed Rezaie, Vahid Asgharzadeh, Behroz Mahdavipoor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2020
Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in the Azeri Population of IranMahya Pourostadi, Simin Sattarpour, Behroz M Poor, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Basic and Clinical Physiology and Pharmacology|August 11, 2021
Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibilityAmin Daei Sorkhabi, Aila Sarkesh, Alireza Daei Sorkhabi, et al.
Tanaffos|February 10, 2016
An Innovative Method to Enhance the Modified DOTS for TB PatientsHassan Yekrang Sis, Jalil Rashedi, Fariba Azabdaftari, et al.
Infectious Disorders Drug Targets|December 29, 2018
Stopping of the Downtrend of Tuberculosis in Iran, a Systematic Review of Associated Risk FactorsManouchehr Fadaee, Jalil Rashedi, Sepideh Arabi, et al.
Le Infezioni in Medicina|December 1, 2020
Risk Factors for COVID-19Jalil Rashedi, Behroz Mahdavi Poor, Vahid Asgharzadeh, et al.
Iranian Journal of Public Health|September 27, 2021
Why the COVID-19 Is Not Significantly Reduced in Iran?Mohammad Asgharzadeh, Behroz Mahdavipoor, Vahid Asgharzadeh, et al.
Iranian Journal of Allergy, Asthma, and Immunology|July 18, 2016
Association of Promoter Polymorphisms of Interleukin-10 and Interferon-Gamma Genes with Tuberculosis in Azeri Population of IranMohammad Asgharzadeh, Sajjad Ghorghanlu, Jalil Rashedi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 7, 2023
The Association between Diet and Multiple SclerosisVahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Behroz Mahdavi Poor, et al.
Infectious Disorders Drug Targets|July 20, 2019
Tuberculosis and Diabetes Mellitus in Northwest of IranMahdi Asghari Ozma, Jalil Rashedi, Behroz Mahdavi Poor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 28, 2026
Association Between Early-Life Self-Medication and Multiple Sclerosis Risk: A Case-Control StudySeyyed Amin Seyyed Rezaie, Vahid Asgharzadeh, Behroz Mahdavipoor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2020
Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in the Azeri Population of IranMahya Pourostadi, Simin Sattarpour, Behroz M Poor, et al.
Pageof 6